Skip to main content

New patients, new disorders, new drugs and the rise of prescriptions

The rise of prescription of psychotropic drugs is a major healthcare problem namely in Psychiatry. The reason of the rise is not clear and many questions remain unanswered. Furthermore, we have more patients, more drugs, more resistant and demanding patients and more polypharmacy. Inappropriate prescribing and lack of rational is not uncommon and prescribing education is also a main concern. Although, the use of guidelines for treatment could make clinical work easier they differ in their objectives and contents. We will discuss the doctor's capacity to make more diagnosis, the problematic of out of label prescriptions and the potential of abuse of some medication and the implications in the rise of prescription. The continuous update and training in clinical psychopharmacology and joint decision-making process between clinicians will allow a rational approach to treatment.

Author information



Corresponding author

Correspondence to Luis Camara Pestana.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Pestana, L.C. New patients, new disorders, new drugs and the rise of prescriptions. Ann Gen Psychiatry 9, S71 (2010).

Download citation


  • Public Health
  • Main Concern
  • Psychotropic Drug
  • Rational Approach
  • Clinical Work